Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.58 |
| ▸ | IL23R | Q5VWK5 | 4/20 | 0.55 |
| ▸ | NPY4R | P50391 | 5/20 | 0.54 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.54 |
| ▸ | NPY1R | P25929 | 3/20 | 0.54 |
| ▸ | NPY2R | P49146 | 1/20 | 0.54 |
| ▸ | GLP1R | P43220 | 3/20 | 0.54 |
| ▸ | F2 | P00734 | 4/20 | 0.53 |
| ▸ | BECN1 | Q14457 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8893999 | 0.95 | TFPI (0.53) | TFPIIL23RNPY4RGLP1RF2 | |
| SCHEMBL8893440 | 0.95 | TFPI (0.57) | TFPIIL23RGLP1RF2 | |
| SCHEMBL8895830 | 0.95 | TFPI (0.57) | TFPIIL23RGLP1RF2 | |
| SCHEMBL29836292 | 0.89 | GLP1R (0.60) | GLP1R | |
| SCHEMBL30168791 | 0.89 | GLP1R (0.59) | GLP1R | |
| SCHEMBL29836187 | 0.88 | GLP1R (0.63) | GLP1R | |
| SCHEMBL29836537 | 0.88 | GLP1R (0.63) | GLP1R | |
| SCHEMBL8896224 | 0.88 | GLP1R (0.53) | TFPIGLP1R | |
| SCHEMBL29836519 | 0.88 | GLP1R (0.59) | GLP1R | |
| SCHEMBL30168743 | 0.88 | GLP1R (0.63) | GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5618785-A | ANTIISCHEMIC AGENTS, ANTITUMOR AGENTS, ANTIARTHRITIC AGENTS | CENTOCOR, INC. (US) | 1997-04-08 | — | — | US | disclosed |
| WO-1995014787-A1 | PEPTIDE INHIBITORS OF SELECTING BINDING | CENTOCOR, INC. (US) | 1995-06-01 | — | — | WO | disclosed |